Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PERRIGO R AND D

  • FDA Approval
  • Oct. 09, 2023, 11:49 UTC
  • 30
  • 0 comments

FDA approve DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM

Comment Full text

NAARI PTE LTD

  • FDA Approval
  • Oct. 09, 2023, 11:49 UTC
  • 33
  • 0 comments

FDA approve DROSPIRENONE; ETHINYL ESTRADIOL

Comment Full text

TEVA PHARMS

  • FDA Approval
  • Oct. 09, 2023, 11:49 UTC
  • 34
  • 0 comments

FDA approve MONTELUKAST SODIUM

Comment Full text

PERRIGO

  • FDA Approval
  • Oct. 09, 2023, 11:49 UTC
  • 36
  • 0 comments

FDA approve RANITIDINE HYDROCHLORIDE

Comment Full text

DR REDDYS LABS LTD

  • FDA Approval
  • Oct. 09, 2023, 11:49 UTC
  • 37
  • 0 comments

FDA approve ONDANSETRON HYDROCHLORIDE

Comment Full text

HUMANWELL PHARMACEUTICAL US INC

  • FDA Approval
  • Oct. 06, 2023, 18:12 UTC
  • 35
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

MSN LABORATORIES PRIVATE LTD

  • FDA Approval
  • Oct. 06, 2023, 17:54 UTC
  • 34
  • 0 comments

FDA approve TRABECTEDIN

Comment Full text

ARCUTIS

  • FDA Approval
  • Oct. 06, 2023, 11:43 UTC
  • 31
  • 0 comments

FDA approve ROFLUMILAST

Comment Full text

RUBICON RESEARCH PRIVATE LTD

  • FDA Approval
  • Oct. 05, 2023, 17:19 UTC
  • 32
  • 0 comments

FDA approve GLIPIZIDE

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • Oct. 05, 2023, 17:19 UTC
  • 32
  • 0 comments

FDA approve OSELTAMIVIR PHOSPHATE

Comment Full text
  • Previous
  • 662
  • 663
  • 664
  • 665
  • 666
  • Next

Search

News categories

  • Technical Exchange News(11989)
  • Event(5090)
  • SEC News(247981)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(149247)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin